Peer-reviewedCC BYDiagnostics (Basel, Switzerland)
Generative Forecasting of Longitudinal 3D-OCT Under Anti-VEGF Therapy for Diabetic Macular Edema
- 1College of Control Science and Engineering, , Hangzhou 310027, China;
- 2Department of Neurosurgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China;
- 3Department of Biomedical Engineering and Sports Technology, The , Hong Kong, China
Related
- Efficacy and Clinical Predictors of Topical NSAIDs as Bridging Therapy for Diabetic Macular Edema: A Systematic Review and Meta-Analysis
- Switching to Faricimab in Patients with Chronic Diabetic Macular Edema Refractory to Previous Anti-VEGF Therapy: Morphological and Functional Outcomes Including Optical Coherence Tomography Angiography Parameters
- Early clinical outcomes after switching to faricimab in previously treated diabetic macular edema
- Prevalence and Optical Coherence Tomography Biomarker Profile in Diabetic Macular Edema Among Occidental Mexican Patients
- Epivascular glia and macular pigment changes after faricimab or aflibercept during the loading phase in diabetic macular edema: a prospective non-randomized pilot study
BibTeX
@article{feng2026generative,
title = {{Generative Forecasting of Longitudinal 3D-OCT Under Anti-VEGF Therapy for Diabetic Macular Edema}},
author = {Yuxiang Feng and Chaofeng Liang and Shujun Wang},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13703180},
note = {CC BY},
}
RIS
TY - JOUR
TI - Generative Forecasting of Longitudinal 3D-OCT Under Anti-VEGF Therapy for Diabetic Macular Edema
AU - Yuxiang Feng
AU - Chaofeng Liang
AU - Shujun Wang
PY - 2026
DA - 2026/10/01
JO - Diagnostics (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13703180
SN - 2075-4418
ER -